Mevis v. Eli Lilly & Co.

220 A.D.2d 34, 642 N.Y.S.2d 677
Appellate Division of the Supreme Court of the State of New York·Decided May 23, 1996·Published·Cited by 2 cases

Opinions

OPINION OF THE COURT

Sullivan, J. P.

This is a products liability action against numerous pharmaceutical manufacturers for personal injuries plaintiff allegedly sustained as a result of in útero exposure to diethylstilbestrol (DES). The parties agreed before the IAS Court that plaintiff’s cause of action accrued in Indiana and that, under the borrowing statute, the Indiana Statute of Limitations applies to this case since, facially, it is shorter than the applicable New York period of limitations. (See, e.g., Besser v Squibb & Sons, 146 AD2d 107, affd 75 NY2d 847.)

Free access — add to your briefcase to read the full text and ask questions with AI

Mevis v. Eli Lilly & Co., 220 A.D.2d 34, 642 N.Y.S.2d 677 (N.Y. Ct. App. 1996).

220 A.D.2d 34 (Mevis v. Eli Lilly & Co.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Reed v. City of Evansville
956 N.E.2d 684 (Indiana Court of Appeals, 2011)